Amyris saw the highest growth of 349% in patent filings in February and 99% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 49% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Amyris’s patent filings and grants. Buy the databook here.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Amyris has been focused on protecting inventions in United States(US) with eight publications in Q1 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 55% filings and 50% grants. The United States(US), Brazil(BR), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Amyris is filings its patents. Among the top granted patent authorities, Amyris has 50% of its grants in United States(US), 25% in European Patent Office(EPO) and 25% in South Korea(KR).
DSM-Firmenich could be the strongest competitor for Amyris
Patents related to climate change and emissions reduction lead Amyris's portfolio
Amyris has the highest number of patents in climate change followed by, emissions reduction and renewable energy. For climate change, nearly 33% of patents were filed and 33% of patents were granted in Q1 2024.
Cosmetics & toiletries related patents lead Amyris portfolio followed by skincare, and petrochemicals
Amyris has highest number of patents in cosmetics & toiletries followed by skincare, petrochemicals, biofuels, and soft drinks.
For comprehensive analysis of Amyris's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

